Literature DB >> 26722408

In-vitro inhibitory effect of EGFL7-RNAi on endothelial angiogenesis in glioma.

Qiang Li1, Ai-Yue Wang2, Qiong-Guan Xu1, Da-Yuan Liu1, Peng-Xiang Xu1, Dai Yu2.   

Abstract

OBJECTIVE: To investigate the role and mechanism of epidermal growth factor like domain 7 (EGFL7) in glioma angiogenesis by cell co-culture and RNA interference.
METHODS: NSCs-HUVECs co-culture system was established using Transwell culturing techniques. The interactions between glioma and endothelial cells were simulated in-vitro. Cellular expression of EGFL7 in NSCs and HUVEC was targeted and suppressed by lentiviral vector carrying siRNA. The effect of EGFL7 on angiogenesis in glioma in-vitro micro-environment was detected by endothelial cell proliferation, adhesion and tube formation assay.
RESULTS: Following EGFL7 gene silencing, expression of EGFL7 in HUVECs was reduced and cell adhesion capability was inhibited significantly. Endothelial cells failed to form a lumen-like structure after EGFL7 gene silencing, shown by the tube formation assay.
CONCLUSION: By regulating endothelial cell adhesion, EGFL7 plays a key role in the regulation of glioma angiogenesis.

Entities:  

Keywords:  Epidermal growth factor like domain 7; RNA interference; angiogenesis

Mesh:

Substances:

Year:  2015        PMID: 26722408      PMCID: PMC4680353     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  17 in total

Review 1.  EGFL7: a unique angiogenic signaling factor in vascular development and disease.

Authors:  Donna Nichol; Heidi Stuhlmann
Journal:  Blood       Date:  2011-12-07       Impact factor: 22.113

2.  Egfl7 promotes tumor escape from immunity by repressing endothelial cell activation.

Authors:  Suzanne Delfortrie; Sébastien Pinte; Virginie Mattot; Chantal Samson; Gaëlle Villain; Bertrand Caetano; Géraldine Lauridant-Philippin; Marie-Christine Baranzelli; Jacques Bonneterre; François Trottein; Christelle Faveeuw; Fabrice Soncin
Journal:  Cancer Res       Date:  2011-10-28       Impact factor: 12.701

3.  Slowdown promotes muscle integrity by modulating integrin-mediated adhesion at the myotendinous junction.

Authors:  Eliezer Gilsohn; Talila Volk
Journal:  Development       Date:  2010-01-28       Impact factor: 6.868

4.  Prognostic role of epidermal growth factor-like domain 7 protein expression in laryngeal squamous cell carcinoma.

Authors:  J-J Li; X-M Yang; S-H Wang; Q-L Tang
Journal:  J Laryngol Otol       Date:  2011-09-07       Impact factor: 1.469

5.  EGFL7 ligates αvβ3 integrin to enhance vessel formation.

Authors:  Iva Nikolic; Nevenka Dudvarski Stankovic; Frank Bicker; Jeannette Meister; Helene Braun; Khader Awwad; Jan Baumgart; Kirsten Simon; Serge C Thal; Chinmoy Patra; Patrick N Harter; Karl H Plate; Felix B Engel; Stefanie Dimmeler; Johannes A Eble; Michel Mittelbronn; Michael K Schäfer; Benno Jungblut; Emmanouil Chavakis; Ingrid Fleming; Mirko H H Schmidt
Journal:  Blood       Date:  2013-02-05       Impact factor: 22.113

6.  Expression of Egfl7 correlates with low-grade invasive lesions in human breast cancer.

Authors:  Géraldine Philippin-Lauridant; Marie-Christine Baranzelli; Chantal Samson; Charles Fournier; Sébastien Pinte; Virginie Mattot; Jacques Bonneterre; Fabrice Soncin
Journal:  Int J Oncol       Date:  2013-02-08       Impact factor: 5.650

7.  Novel role for epidermal growth factor-like domain 7 in metastasis of human hepatocellular carcinoma.

Authors:  Fan Wu; Lian-Yue Yang; Yun-Feng Li; Di-Peng Ou; Dong-Ping Chen; Chun Fan
Journal:  Hepatology       Date:  2009-12       Impact factor: 17.425

8.  Egfl7 knockdown causes defects in the extension and junctional arrangements of endothelial cells during zebrafish vasculogenesis.

Authors:  Ann De Mazière; Leon Parker; Suzanne Van Dijk; Weilan Ye; Judith Klumperman
Journal:  Dev Dyn       Date:  2008-03       Impact factor: 3.780

9.  EGFL7 regulates the collective migration of endothelial cells by restricting their spatial distribution.

Authors:  Maike Schmidt; Kim Paes; Ann De Mazière; Tanya Smyczek; Stacey Yang; Alane Gray; Dorothy French; Ian Kasman; Judith Klumperman; Dennis S Rice; Weilan Ye
Journal:  Development       Date:  2007-07-11       Impact factor: 6.868

Review 10.  PET/SPECT imaging of hindlimb ischemia: focusing on angiogenesis and blood flow.

Authors:  Hakan Orbay; Hao Hong; Yin Zhang; Weibo Cai
Journal:  Angiogenesis       Date:  2012-11-02       Impact factor: 9.596

View more
  7 in total

Review 1.  The role of exosomal microRNAs in central nervous system diseases.

Authors:  Yifei Yu; Kun Hou; Tong Ji; Xishu Wang; Yining Liu; Yangyang Zheng; Jinying Xu; Yi Hou; Guangfan Chi
Journal:  Mol Cell Biochem       Date:  2021-01-29       Impact factor: 3.396

2.  Bioinformatics Analysis of Stem Cell circ-ASB3 Signaling Pathway and Its Affection on Glioma Biological Characteristics.

Authors:  Li Guowei; Jin Yanping
Journal:  Front Neuroinform       Date:  2022-04-12       Impact factor: 4.081

3.  Collagen Type VI Alpha 3 Chain Promotes Epithelial-Mesenchymal Transition in Bladder Cancer Cells via Transforming Growth Factor β (TGF-β)/Smad Pathway.

Authors:  Yan Huang; Gang Li; Kai Wang; Zhongyi Mu; Qingpeng Xie; Hongchen Qu; Hang Lv; Bin Hu
Journal:  Med Sci Monit       Date:  2018-08-01

4.  EGFL7 enhances surface expression of integrin α5β1 to promote angiogenesis in malignant brain tumors.

Authors:  Nevenka Dudvarski Stanković; Frank Bicker; Stefanie Keller; David Tw Jones; Patrick N Harter; Arne Kienzle; Clarissa Gillmann; Philipp Arnold; Anna Golebiewska; Olivier Keunen; Alf Giese; Andreas von Deimling; Tobias Bäuerle; Simone P Niclou; Michel Mittelbronn; Weilan Ye; Stefan M Pfister; Mirko H Schmidt
Journal:  EMBO Mol Med       Date:  2018-09       Impact factor: 12.137

5.  A positive feed-forward loop between LncRNA-URRCC and EGFL7/P-AKT/FOXO3 signaling promotes proliferation and metastasis of clear cell renal cell carcinoma.

Authors:  Wei Zhai; Rujian Zhu; Junjie Ma; Dongkui Gong; Haimin Zhang; Jin Zhang; Yonghui Chen; Yiran Huang; Junhua Zheng; Wei Xue
Journal:  Mol Cancer       Date:  2019-04-05       Impact factor: 27.401

6.  Mesenchymal stem cell-derived exosomal microRNA-133b suppresses glioma progression via Wnt/β-catenin signaling pathway by targeting EZH2.

Authors:  Haiyang Xu; Guifang Zhao; Yu Zhang; Hong Jiang; Weiyao Wang; Donghai Zhao; Jin Hong; Hongquan Yu; Ling Qi
Journal:  Stem Cell Res Ther       Date:  2019-12-16       Impact factor: 6.832

7.  Bioinformatics analysis reveals a stem cell-expressed circ-Serpine2-mediated miRNA-mRNA regulatory subnetwork in the malignant progression of glioma.

Authors:  Guowei Li; Qing Lan
Journal:  J Transl Med       Date:  2021-10-24       Impact factor: 5.531

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.